Request to Join
has invited you to join this group
Neil Vasan is originally from West Virginia and attended Harvard University. He obtained his MD/PhD from the Yale University School of Medicine where he completed his dissertation research on the structural biology of intracellular trafficking using X-ray crystallography. He completed his Internal Medicine residency at Massachusetts General Hospital and short tracked into the Medical Oncology Fellowship at Memorial Sloan-Kettering Cancer Center. He is a research fellow in the laboratory of José Baselga where he studies mechanisms of sensitivity and resistance to targeted therapies in breast cancer. During 2016-2017 he serves as Chief Fellow in Medical Oncology at Memorial Sloan Kettering Cancer Center.
I am an academic physician scientist with specialty practice in the area of hematologic malignancies. My research focus is on cancer immunology. I have published multiple papers on the biology of the blood cancer multiple myeloma. I am currently in practice and see patient in both the inpatient and outpatient setting. I am also Co-Director of an autologous stem cell transplant program.
Dr. Sunandana Chandra is an Assistant Professor of Medicine in the Division of Hematology Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. She is a Medical Oncologist with a focus in melanoma, Merkel cell carcinoma, and other advanced cutaneous malignancies. She is also involved in the Developmental Therapeutics program at the Lurie Cancer Center. Her research focuses on immunotherapy, the development of predictive and prognostic biomarkers. She also has an interest in the advancement of management of brain metastases in melanoma patients.
Dr. Dreicer is Head of the Section of Medical Oncology and Deputy Director of the University of Virginia Cancer Center. He received his Medical Degree and Master of Science from the University of Texas, Houston. He completed internal medicine residency training at Indiana University and a medical oncology fellowship at the University of Wisconsin. He is a Master of the American College of Physicians and a Fellow of the American Society of Clinical Oncology. Dr. Dreicer is an academic clinical investigator in the area of urologic oncology. He is a former Co-Chair of the NCI GU Steering Committee and served as a member of the American Board of Internal Medicine, Medical Oncology Test Writing Committee for 6 years. Dr. Dreicer has been writing for NEJM Journal Watch Oncology and Hematology since 2006.
Dr. Tsao is a Professor in the Department of Thoracic/Head & Neck Medical Oncology at the University of Texas M.D. Anderson Cancer Center (MDACC). She is the Director of the Mesothelioma Program and the Director of the Thoracic Chemo-Radiation Program at MDACC. Dr. Tsao is a clinician scientist and an expert in the treatment of patients with both thoracic and head and neck cancers. She conducts both clinical and translational laboratory research and focuses on identifying new therapeutic targets and developing novel strategies for the treatment of aerodigestive cancers and mesothelioma. Her research concentrates on individualizing cancer therapy through understanding the molecular mechanisms of disease. Dr. Tsao serves on the SWOG Mesothelioma Steering Committee, SWOG Lung Executive Committee, IASLC Communications Committee, and RTOG Lung Executive Committee, and is on the Scientific Board of the American Radium Society. She has been an Associate Editor of NEJM Journal Watch Oncology and Hematology since 2013.
Dr. Pavan (“Tem”) Bendapudi serves on the staff of Massachusetts General Hospital (MGH) in the Division of Hematology and is assistant professor of medicine at Harvard Medical School. His focus is in the management and biology of bleeding and clotting disorders. Dr. Bendapudi completed his residency in internal medicine at MGH before pursuing further training in transfusion medicine and hematology, both through the Harvard combined fellowship programs. He was the first graduate of his residency program to specialize in both hematology and transfusion medicine and today remains deeply involved in the education of trainees in both areas. Clinically, Dr. Bendapudi maintains an active presence on the inpatient hematology consultation service, the blood bank, and the clinical coagulation laboratory. Dr. Bendapudi’s research laboratory focuses on the biology of coagulation factors and the ways in which bleeding and clotting impact human health.